SIRT1 and metabolic dysfunction-associated steatohepatitis: This effect is linked to changes in the gut microbiota, particularly the increase in the Dorea genus, which promotes NAD+ biosynthesis and SIRT1 activity, contributing to the protective phenotype against NASH [81].